Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
activist investor
Biotech
Elevation faces activist investor demands to wind down
Elevation Oncology has become the second biotech this week to face calls from an activist investor to wind down.
James Waldron
Apr 17, 2025 10:00am
Keros mulls sale, strengthens defense against activist investors
Apr 10, 2025 8:44am
Cyclacel sheds clinical asset in effort to stop cash spiral
Apr 2, 2025 6:01pm
Investor pumps $3M into Cyclacel in return for CEO role
Jan 3, 2025 10:50am
Galapagos’ stock up as fund shows intent to shape its evolution
Aug 26, 2024 8:45am
Masimo sues activist investor Politan, postpones proxy vote
Jul 16, 2024 11:30am
